Drugmaker Takeda's CEO Weber to step down, raises profit forecast
Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates but ...
Takeda CEO Christophe Weber to retire in 2026, Julie Kim to succeed
Takeda (TAK) announced that its board of directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S.
Benzinga.com3d
STAT+: Takeda CEO Christophe Weber to step down following prolonged drop in company shares
Christophe Weber will step down as CEO of Takeda next year, the company announced Thursday, following a dropoff in its share price over the last couple of years. Weber, 59, has led the Japanese ...
Takeda signals 2025 growth with raised guidance, JPY 100B buyback, and new leadership transition
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2025 Management View Christophe Weber, CEO, announced his retirement ...
FiercePharma1d
Fierce Pharma Asia—Takeda's next CEO; Enhertu's novel FDA nod; East Asian American C-suite execs
Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...
Axios on MSN4d
Embracing AI is necessary for legacy industries, leaders say
A commitment to embracing AI and the changing digital world are key to success in legacy industries, Bank of America CEO Brian Moynihan and Takeda Pharmaceutical CEO Christophe Weber said. Why it ...